chr16:3891749-3914639 |
chr16:3913995 |
rs2239316 |
CREBBP |
Cognitive test performance |
intron |
8.94e-05 |
GWASdb |
| chr16:3891749-3914639 |
chr16:3912619 |
rs12446940 |
CREBBP - LOC102724927 |
Neurofibrillary tangles |
intergenic_variant |
4e-06 |
GWAS_Catalog |
| chr16:3986909-4012319 |
chr16:3992783 |
rs11640300 |
NA |
Major depressive disorder |
NA |
1.6e-05 |
GWASdb |
| chr16:3986909-4012319 |
chr16:3994696 |
rs17256183 |
NA |
Major depressive disorder |
NA |
2.02e-05 |
GWASdb |
| chr16:3986909-4012319 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3986909-4012319 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3986909-4012319 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3986909-4012319 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3986909-4012319 |
chr16:3988386 |
rs2444217 |
ADCY9 |
Body mass index |
intron_variant |
9e-08 |
GWAS_Catalog |
| chr16:3993995-4012640 |
chr16:3994696 |
rs17256183 |
NA |
Major depressive disorder |
NA |
2.02e-05 |
GWASdb |
| chr16:3993995-4012640 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3993995-4012640 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3993995-4012640 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3993995-4012640 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3989285-4031382 |
chr16:3992783 |
rs11640300 |
NA |
Major depressive disorder |
NA |
1.6e-05 |
GWASdb |
| chr16:3989285-4031382 |
chr16:3994696 |
rs17256183 |
NA |
Major depressive disorder |
NA |
2.02e-05 |
GWASdb |
| chr16:3989285-4031382 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3989285-4031382 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3989285-4031382 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3989285-4031382 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3989285-4031382 |
chr16:4013467 |
rs2531995 |
ADCY9 |
Obesity |
UTR-3 |
4e-08 |
GWASdb |
| chr16:3989285-4031382 |
chr16:4013467 |
rs2531995 |
ADCY9 |
Body mass index |
UTR-3 |
7e-08 |
GWASdb |
| chr16:3989285-4031382 |
chr16:4016049 |
rs11543317 |
ADCY9 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
cds-synon |
6.11e-05 |
GWASdb |
| chr16:3989285-4031382 |
chr16:4025385 |
rs2238436 |
ADCY9 |
Obesity (extreme) |
intron |
0.000104 |
GWASdb |
| chr16:3989285-4031382 |
chr16:4027423 |
rs2072346 |
ADCY9 |
Obesity (extreme) |
intron |
0.000522 |
GWASdb |
| chr16:3989285-4031382 |
chr16:4027605 |
rs2240735 |
ADCY9 |
Obesity (extreme) |
cds-synon |
0.000103 |
GWASdb |
| chr16:3989285-4031382 |
chr16:4031348 |
rs2238439 |
ADCY9 |
Obesity (extreme) |
intron |
0.000453 |
GWASdb |
| chr16:3989285-4031382 |
chr16:4031348 |
rs2238439 |
ADCY9 |
Heart Failure |
intron |
0.000261 |
GWASdb |
| chr16:3989285-4031382 |
chr16:4015582 |
rs1967309 |
ADCY9 |
Response to Dalcetrapib treatment in acute coronary syndrome |
non_coding_transcript_exon_variant |
2e-08 |
GWAS_Catalog |
| chr16:3989285-4031382 |
chr16:4021721 |
rs67335251 |
ADCY9 |
Diisocyanate-induced asthma |
intron_variant |
2e-06 |
GWAS_Catalog |
| chr16:3989202-4033055 |
chr16:3992783 |
rs11640300 |
NA |
Major depressive disorder |
NA |
1.6e-05 |
GWASdb |
| chr16:3989202-4033055 |
chr16:3994696 |
rs17256183 |
NA |
Major depressive disorder |
NA |
2.02e-05 |
GWASdb |
| chr16:3989202-4033055 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3989202-4033055 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3989202-4033055 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3989202-4033055 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3989202-4033055 |
chr16:4013467 |
rs2531995 |
ADCY9 |
Obesity |
UTR-3 |
4e-08 |
GWASdb |
| chr16:3989202-4033055 |
chr16:4013467 |
rs2531995 |
ADCY9 |
Body mass index |
UTR-3 |
7e-08 |
GWASdb |
| chr16:3989202-4033055 |
chr16:4016049 |
rs11543317 |
ADCY9 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
cds-synon |
6.11e-05 |
GWASdb |
| chr16:3989202-4033055 |
chr16:4025385 |
rs2238436 |
ADCY9 |
Obesity (extreme) |
intron |
0.000104 |
GWASdb |
| chr16:3989202-4033055 |
chr16:4027423 |
rs2072346 |
ADCY9 |
Obesity (extreme) |
intron |
0.000522 |
GWASdb |
| chr16:3989202-4033055 |
chr16:4027605 |
rs2240735 |
ADCY9 |
Obesity (extreme) |
cds-synon |
0.000103 |
GWASdb |
| chr16:3989202-4033055 |
chr16:4031348 |
rs2238439 |
ADCY9 |
Obesity (extreme) |
intron |
0.000453 |
GWASdb |
| chr16:3989202-4033055 |
chr16:4031348 |
rs2238439 |
ADCY9 |
Heart Failure |
intron |
0.000261 |
GWASdb |
| chr16:3989202-4033055 |
chr16:4015582 |
rs1967309 |
ADCY9 |
Response to Dalcetrapib treatment in acute coronary syndrome |
non_coding_transcript_exon_variant |
2e-08 |
GWAS_Catalog |
| chr16:3989202-4033055 |
chr16:4021721 |
rs67335251 |
ADCY9 |
Diisocyanate-induced asthma |
intron_variant |
2e-06 |
GWAS_Catalog |
| chr16:4006914-4031563 |
chr16:4013467 |
rs2531995 |
ADCY9 |
Obesity |
UTR-3 |
4e-08 |
GWASdb |
| chr16:4006914-4031563 |
chr16:4013467 |
rs2531995 |
ADCY9 |
Body mass index |
UTR-3 |
7e-08 |
GWASdb |
| chr16:4006914-4031563 |
chr16:4016049 |
rs11543317 |
ADCY9 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
cds-synon |
6.11e-05 |
GWASdb |
| chr16:4006914-4031563 |
chr16:4025385 |
rs2238436 |
ADCY9 |
Obesity (extreme) |
intron |
0.000104 |
GWASdb |
| chr16:4006914-4031563 |
chr16:4027423 |
rs2072346 |
ADCY9 |
Obesity (extreme) |
intron |
0.000522 |
GWASdb |
| chr16:4006914-4031563 |
chr16:4027605 |
rs2240735 |
ADCY9 |
Obesity (extreme) |
cds-synon |
0.000103 |
GWASdb |
| chr16:4006914-4031563 |
chr16:4031348 |
rs2238439 |
ADCY9 |
Obesity (extreme) |
intron |
0.000453 |
GWASdb |
| chr16:4006914-4031563 |
chr16:4031348 |
rs2238439 |
ADCY9 |
Heart Failure |
intron |
0.000261 |
GWASdb |
| chr16:4006914-4031563 |
chr16:4015582 |
rs1967309 |
ADCY9 |
Response to Dalcetrapib treatment in acute coronary syndrome |
non_coding_transcript_exon_variant |
2e-08 |
GWAS_Catalog |
| chr16:4006914-4031563 |
chr16:4021721 |
rs67335251 |
ADCY9 |
Diisocyanate-induced asthma |
intron_variant |
2e-06 |
GWAS_Catalog |
| chr16:3988764-4012661 |
chr16:3992783 |
rs11640300 |
NA |
Major depressive disorder |
NA |
1.6e-05 |
GWASdb |
| chr16:3988764-4012661 |
chr16:3994696 |
rs17256183 |
NA |
Major depressive disorder |
NA |
2.02e-05 |
GWASdb |
| chr16:3988764-4012661 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3988764-4012661 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3988764-4012661 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3988764-4012661 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3989428-4031367 |
chr16:3992783 |
rs11640300 |
NA |
Major depressive disorder |
NA |
1.6e-05 |
GWASdb |
| chr16:3989428-4031367 |
chr16:3994696 |
rs17256183 |
NA |
Major depressive disorder |
NA |
2.02e-05 |
GWASdb |
| chr16:3989428-4031367 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3989428-4031367 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3989428-4031367 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3989428-4031367 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3989428-4031367 |
chr16:4013467 |
rs2531995 |
ADCY9 |
Obesity |
UTR-3 |
4e-08 |
GWASdb |
| chr16:3989428-4031367 |
chr16:4013467 |
rs2531995 |
ADCY9 |
Body mass index |
UTR-3 |
7e-08 |
GWASdb |
| chr16:3989428-4031367 |
chr16:4016049 |
rs11543317 |
ADCY9 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
cds-synon |
6.11e-05 |
GWASdb |
| chr16:3989428-4031367 |
chr16:4025385 |
rs2238436 |
ADCY9 |
Obesity (extreme) |
intron |
0.000104 |
GWASdb |
| chr16:3989428-4031367 |
chr16:4027423 |
rs2072346 |
ADCY9 |
Obesity (extreme) |
intron |
0.000522 |
GWASdb |
| chr16:3989428-4031367 |
chr16:4027605 |
rs2240735 |
ADCY9 |
Obesity (extreme) |
cds-synon |
0.000103 |
GWASdb |
| chr16:3989428-4031367 |
chr16:4031348 |
rs2238439 |
ADCY9 |
Obesity (extreme) |
intron |
0.000453 |
GWASdb |
| chr16:3989428-4031367 |
chr16:4031348 |
rs2238439 |
ADCY9 |
Heart Failure |
intron |
0.000261 |
GWASdb |
| chr16:3989428-4031367 |
chr16:4015582 |
rs1967309 |
ADCY9 |
Response to Dalcetrapib treatment in acute coronary syndrome |
non_coding_transcript_exon_variant |
2e-08 |
GWAS_Catalog |
| chr16:3989428-4031367 |
chr16:4021721 |
rs67335251 |
ADCY9 |
Diisocyanate-induced asthma |
intron_variant |
2e-06 |
GWAS_Catalog |
| chr16:3988408-4012789 |
chr16:3992783 |
rs11640300 |
NA |
Major depressive disorder |
NA |
1.6e-05 |
GWASdb |
| chr16:3988408-4012789 |
chr16:3994696 |
rs17256183 |
NA |
Major depressive disorder |
NA |
2.02e-05 |
GWASdb |
| chr16:3988408-4012789 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3988408-4012789 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3988408-4012789 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3988408-4012789 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3988557-4012167 |
chr16:3992783 |
rs11640300 |
NA |
Major depressive disorder |
NA |
1.6e-05 |
GWASdb |
| chr16:3988557-4012167 |
chr16:3994696 |
rs17256183 |
NA |
Major depressive disorder |
NA |
2.02e-05 |
GWASdb |
| chr16:3988557-4012167 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3988557-4012167 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3988557-4012167 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3988557-4012167 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3995445-4022584 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3995445-4022584 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3995445-4022584 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3995445-4022584 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3995445-4022584 |
chr16:4013467 |
rs2531995 |
ADCY9 |
Obesity |
UTR-3 |
4e-08 |
GWASdb |
| chr16:3995445-4022584 |
chr16:4013467 |
rs2531995 |
ADCY9 |
Body mass index |
UTR-3 |
7e-08 |
GWASdb |
| chr16:3995445-4022584 |
chr16:4016049 |
rs11543317 |
ADCY9 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
cds-synon |
6.11e-05 |
GWASdb |
| chr16:3995445-4022584 |
chr16:4015582 |
rs1967309 |
ADCY9 |
Response to Dalcetrapib treatment in acute coronary syndrome |
non_coding_transcript_exon_variant |
2e-08 |
GWAS_Catalog |
| chr16:3995445-4022584 |
chr16:4021721 |
rs67335251 |
ADCY9 |
Diisocyanate-induced asthma |
intron_variant |
2e-06 |
GWAS_Catalog |
| chr16:3995518-4012261 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3995518-4012261 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3995518-4012261 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3995518-4012261 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3988506-4005218 |
chr16:3992783 |
rs11640300 |
NA |
Major depressive disorder |
NA |
1.6e-05 |
GWASdb |
| chr16:3988506-4005218 |
chr16:3994696 |
rs17256183 |
NA |
Major depressive disorder |
NA |
2.02e-05 |
GWASdb |
| chr16:3988506-4005218 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3988506-4005218 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3988506-4005218 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3988506-4005218 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3988674-4012138 |
chr16:3992783 |
rs11640300 |
NA |
Major depressive disorder |
NA |
1.6e-05 |
GWASdb |
| chr16:3988674-4012138 |
chr16:3994696 |
rs17256183 |
NA |
Major depressive disorder |
NA |
2.02e-05 |
GWASdb |
| chr16:3988674-4012138 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3988674-4012138 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3988674-4012138 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3988674-4012138 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3995518-4012261 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3995518-4012261 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3995518-4012261 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3995518-4012261 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3988315-4034128 |
chr16:3992783 |
rs11640300 |
NA |
Major depressive disorder |
NA |
1.6e-05 |
GWASdb |
| chr16:3988315-4034128 |
chr16:3994696 |
rs17256183 |
NA |
Major depressive disorder |
NA |
2.02e-05 |
GWASdb |
| chr16:3988315-4034128 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000572 |
GWASdb |
| chr16:3988315-4034128 |
chr16:3998630 |
rs7197403 |
NA |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
NA |
0.000583 |
GWASdb |
| chr16:3988315-4034128 |
chr16:3999584 |
rs2283491 |
NA |
Major depressive disorder |
NA |
6e-04 |
GWASdb |
| chr16:3988315-4034128 |
chr16:4002022 |
rs1978300 |
NA |
Type 2 diabetes |
NA |
0.000621 |
GWASdb |
| chr16:3988315-4034128 |
chr16:4013467 |
rs2531995 |
ADCY9 |
Obesity |
UTR-3 |
4e-08 |
GWASdb |
| chr16:3988315-4034128 |
chr16:4013467 |
rs2531995 |
ADCY9 |
Body mass index |
UTR-3 |
7e-08 |
GWASdb |
| chr16:3988315-4034128 |
chr16:4016049 |
rs11543317 |
ADCY9 |
Response to statin treatment (atorvastatin), change in cholesterol levels |
cds-synon |
6.11e-05 |
GWASdb |
| chr16:3988315-4034128 |
chr16:4025385 |
rs2238436 |
ADCY9 |
Obesity (extreme) |
intron |
0.000104 |
GWASdb |
| chr16:3988315-4034128 |
chr16:4027423 |
rs2072346 |
ADCY9 |
Obesity (extreme) |
intron |
0.000522 |
GWASdb |
| chr16:3988315-4034128 |
chr16:4027605 |
rs2240735 |
ADCY9 |
Obesity (extreme) |
cds-synon |
0.000103 |
GWASdb |
| chr16:3988315-4034128 |
chr16:4031348 |
rs2238439 |
ADCY9 |
Obesity (extreme) |
intron |
0.000453 |
GWASdb |
| chr16:3988315-4034128 |
chr16:4031348 |
rs2238439 |
ADCY9 |
Heart Failure |
intron |
0.000261 |
GWASdb |
| chr16:3988315-4034128 |
chr16:4033097 |
rs2531982 |
ADCY9 |
Obesity (extreme) |
intron |
0.000164 |
GWASdb |
| chr16:3988315-4034128 |
chr16:4033436 |
rs2230739 |
ADCY9 |
Pulmonary function in asthmatics |
missense |
6.25e-05 |
GWASdb |
| chr16:3988315-4034128 |
chr16:3988386 |
rs2444217 |
ADCY9 |
Body mass index |
intron_variant |
9e-08 |
GWAS_Catalog |
| chr16:3988315-4034128 |
chr16:4015582 |
rs1967309 |
ADCY9 |
Response to Dalcetrapib treatment in acute coronary syndrome |
non_coding_transcript_exon_variant |
2e-08 |
GWAS_Catalog |
| chr16:3988315-4034128 |
chr16:4021721 |
rs67335251 |
ADCY9 |
Diisocyanate-induced asthma |
intron_variant |
2e-06 |
GWAS_Catalog |